Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

被引:373
作者
Li, Zhiqiang [1 ]
Razavi, Pedram [1 ,2 ,3 ]
Li, Qing [1 ]
Toy, Weiyi [1 ]
Liu, Bo [1 ]
Ping, Christina [2 ]
Hsieh, Wilson [1 ]
Sanchez-Vega, Francisco [1 ]
Brown, David N. [4 ]
Paula, Arnaud F. Da Cruz [4 ]
Morris, Luc [1 ]
Selenica, Pier [3 ]
Eichenberger, Emily [3 ]
Shen, Ronglai [5 ]
Schultz, Nikolaus [1 ]
Rosen, Neal [2 ,3 ]
Scaltriti, Maurizio [1 ,4 ]
Brogi, Edi [4 ]
Baselga, Jose [1 ,2 ,6 ]
Reis-Filho, Jorge S. [4 ]
Chandarlapaty, Sarat [1 ,2 ,3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[2] MSKCC, Breast Med Serv, Dept Med, New York, NY 10065 USA
[3] Weill Cornell Med Coll, New York, NY 10065 USA
[4] MSKCC, Dept Pathol, New York, NY 10065 USA
[5] MSKCC, Dept Epidemiol & Biostat, New York, NY 10065 USA
[6] Vall dHebron Inst Oncol, Barcelona, Spain
关键词
BREAST-CANCER; MUTATIONAL LANDSCAPE; CADHERIN ACTS; GENE; ABEMACICLIB; PALBOCICLIB; DROSOPHILA; UPSTREAM; GROWTH; TAZ;
D O I
10.1016/j.ccell.2018.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin dependent kinase 4/6 (CDK4/6) inhibitors (CDK4/6i) are effective in breast cancer; however, drug resistance is frequently encountered and poorly understood. We conducted a genomic analysis of 348 estrogen receptor-positive (ER+) breast cancers treated with CDK4/6i and identified loss-of-function mutations affecting FAT1 and RB1 linked to drug resistance. FAT1 loss led to marked elevations in CDK6, the suppression of which restored sensitivity to CDK4/6i. The induction of CDK6 was mediated by the Hippo pathway with accumulation of YAP and TAZ transcription factors on the CDK6 promoter. Genomic alterations in other Hippo pathway components were also found to promote CDK4/6i resistance. These findings uncover a tumor suppressor function of Hippo signaling in ER+ breast cancer and establish FAT1 loss as a mechanism of resistance to CDK4/6i.
引用
收藏
页码:893 / +
页数:21
相关论文
共 54 条
[41]   FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing [J].
Shen, Ronglai ;
Seshan, Venkatraman E. .
NUCLEIC ACIDS RESEARCH, 2016, 44 (16)
[42]   Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models [J].
Shihab, Hashem A. ;
Gough, Julian ;
Cooper, David N. ;
Stenson, Peter D. ;
Barker, Gary L. A. ;
Edwards, Keith J. ;
Day, Ian N. M. ;
Gaunt, Tom R. .
HUMAN MUTATION, 2013, 34 (01) :57-65
[43]   The tumor-suppressor gene fat controls tissue growth upstream of expanded in the Hippo signaling pathway [J].
Silva, Elizabeth ;
Tsatskis, Yonit ;
Gardano, Laura ;
Tapon, Nic ;
McNeill, Helen .
CURRENT BIOLOGY, 2006, 16 (21) :2081-2089
[44]   Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development [J].
Skouloudaki, Kassiani ;
Puetz, Michael ;
Simons, Matias ;
Courbard, Jean-Remy ;
Boehlke, Christopher ;
Hartleben, Bjoern ;
Engel, Christina ;
Moeller, Marcus J. ;
Englert, Christoph ;
Bollig, Frank ;
Schaefer, Tobias ;
Ramachandran, Haribaskar ;
Mlodzik, Marek ;
Huber, Tobias B. ;
Kuehn, E. Wolfgang ;
Kim, Emily ;
Kramer-Zucker, Albrecht ;
Walz, Gerd .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (21) :8579-8584
[45]   MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy [J].
Sledge, George W., Jr. ;
Toi, Masakazu ;
Neven, Patrick ;
Sohn, Joohyuk ;
Inoue, Kenichi ;
Pivot, Xavier ;
Burdaeva, Olga ;
Okera, Meena ;
Masuda, Norikazu ;
Kaufman, Peter A. ;
Koh, Han ;
Grischke, Eva-Maria ;
Frenzel, Martin ;
Lin, Yong ;
Barriga, Susana ;
Smith, Ian C. ;
Bourayou, Nawel ;
Llombart-Cussac, Antonio .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (25) :2875-+
[46]   Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles [J].
Subramanian, A ;
Tamayo, P ;
Mootha, VK ;
Mukherjee, S ;
Ebert, BL ;
Gillette, MA ;
Paulovich, A ;
Pomeroy, SL ;
Golub, TR ;
Lander, ES ;
Mesirov, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15545-15550
[47]   ESR1 ligand-binding domain mutations in hormone-resistant breast cancer [J].
Toy, Weiyi ;
Shen, Yang ;
Won, Helen ;
Green, Bradley ;
Sakr, Rita A. ;
Will, Marie ;
Li, Zhiqiang ;
Gala, Kinisha ;
Fanning, Sean ;
King, Tari A. ;
Hudis, Clifford ;
Chen, David ;
Taran, Tetiana ;
Hortobagyi, Gabriel ;
Greene, Geoffrey ;
Berger, Michael ;
Baselga, Jose ;
Chandarlapaty, Sarat .
NATURE GENETICS, 2013, 45 (12) :1439-U189
[48]   Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer [J].
Turner, Nicholas C. ;
Ro, Jungsil ;
Andre, Fabrice ;
Loi, Sherene ;
Verma, Sunil ;
Iwata, Hiroji ;
Harbeck, Nadia ;
Loibl, Sibylle ;
Bartlett, Cynthia Huang ;
Zhang, Ke ;
Giorgetti, Carla ;
Randolph, Sophia ;
Koehler, Maria ;
Cristofanilli, Massimo .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03) :209-219
[49]   Expanded and fat regulate growth and differentiation in the Drosophila eye through multiple signaling pathways [J].
Tyler, David M. ;
Baker, Nicholas E. .
DEVELOPMENTAL BIOLOGY, 2007, 305 (01) :187-201
[50]   The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size [J].
Willecke, Maria ;
Hamaratoglu, Fisun ;
Kango-Singh, Madhuri ;
Udan, Ryan ;
Chen, Chiao-lin ;
Tao, Chunyao ;
Zhang, Xinwei ;
Halder, Georg .
CURRENT BIOLOGY, 2006, 16 (21) :2090-2100